|
Post by peppy on Feb 23, 2017 11:10:47 GMT -5
The other big component I think is going to be in the direct-to-consumer area. So we are going to be doing more aggressive consumer advertising, including television, which everybody is surprised, we have a commercial into production even as we speak. It will probably be awhile before we get it to the FDA and on the air. And even then, don’t look for it on your next Super Bowl. It’s going to be more targeted in a few markets and we want to see before we invest really huge amounts of money that it actually has the effect, we expect it will and some target marketing things. So it’s going to be kind of piloted out. We also have a TV series we are sponsoring later in the year. We are still negotiating some of the aspects of that, but we hope we will hopefully more details to announce for essentially reality TV show based on diabetes that we will sponsor and I think Afrezza will be – I hope we will be figuring prominently in that. seekingalpha.com/article/4036493-mannkinds-mnkd-ceo-matt-pfeffer-presents-jpmorgan-healthcare-conference-transcript?page=5
|
|
|
Post by orlon on Feb 23, 2017 11:58:03 GMT -5
Anyone notice the PPS today while being distracted by Charles Mattocks, someone I never heard of until I started reading some posts this am? Stay with the bottom line thought...no sales=no revenue=no increase in PPS. I don't see Mattocks in this equation. Please...stop the hype.
|
|
|
Post by aderynprin on Feb 23, 2017 12:00:08 GMT -5
Personally, I think Mannkind's focus should be on commercials that are 100% about Afrezza and guaranteed to air. The company simply doesn't have the time or money to be contemplating sponsorship of a reality show that has a very slim chance of being successful. This might be something for them to consider in the future, but not right now.
|
|